Repros Therapeutics Inc (RPRX)

[io_io]

<<<" I was actually wondering what you (and others) think we might hear at the next couple of public outings for JP in 2nd wk of Feb. More details of the endo P2, which might give DD more creativity challenges? Enrolment updates on all the ongoing studies? Date for EOP2 mtg? Anything at all on safety results? Other? ">>>

Actually I cant help, but I would like an enrollment update. He has been quiet on that subject.

By the way, you recently posted to me on DORB.ob, and it looks like you still hold it. I posted back (whether you got to see it or not) that I admired them enormously for their worldwide compassionate use program. But I would sell it after the recent double. They have years to go with their trials, and unless they get a lot of Rivax grant money, see no reason to hold them in 2009 when everything else is on sale.